Related references
Note: Only part of the references are listed.Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies
H. Zuo et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Interferon-γ-Induced Inflammatory Markers and the Risk of Cancer: The Hordaland Health Study
Hui Zuo et al.
CANCER (2014)
Recruitment of Immune Cells Across Atrial Endocardium in Human Atrial Fibrillation
Takeshi Yamashita et al.
CIRCULATION JOURNAL (2010)
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
David Conen et al.
EUROPEAN HEART JOURNAL (2010)
Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation
Renate B. Schnabel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Neopterin and Cardiovascular Disease: Growing Evidence for a Role in Patient Risk Stratification
Pablo Avanzas et al.
CLINICAL CHEMISTRY (2009)
Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions
T. Adachi et al.
HEART (2007)
Role of inflammation in initiation and perpetuation of atrial fibrillation - A systematic review of the published data
Tim T. Issac et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Long-term prognostic value of neopterin a novel marker of monocyte activation in patients with acute coronary syndrome
Kausik K. Ray et al.
CIRCULATION (2007)
Neopterin: Still a forgotten biomarker
JC Kaski et al.
CLINICAL CHEMISTRY (2005)
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris
E Zouridakis et al.
CIRCULATION (2004)
Inflammation as a risk factor for atrial fibrillation
RJ Aviles et al.
CIRCULATION (2003)
Share Paper
